Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (1 trial)
docetaxel (taxotere) (2 trials)
fluorouracil (efudex) (2 trials)
irinotecan (Camptosar) (1 trial)
leucovorin (1 trial)
aldesleukin (Proleukin) (1 trial)
sorafenib (nexavar) (3 trials)
Adenocarcinoma (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Esophageal Neoplasms (Phase 3)
Neoplasm Metastasis (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (7 total)